Published in Cancer Weekly, April 27th, 2004
In the study investigating KOS-862 and carboplatin ("KOS-862 (Epothilone D) and Carboplatin Demonstrate In Vitro and In Vivo Synergy Against...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.